E&C Republican Leaders Press FDA on OxyContin Labeling Change
10.14.2020
Washington, D.C. - Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Representative Morgan Griffith (R-VA) sent a letter to Food and Drug Administration (FDA) Commissioner Stephen Hahn, M.D., to request information on the FDA approval of a OxyContin label change in 2001.
The inquiry follows a briefing FDA provided at the request of bipartisan E&C leaders, in which the FDA presented information they believed showed the opioid crisis was not exacerbated by their decision to approve the change...